SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Oncotelic Therapeutics, Inc.
@OTLC_InsiderForm 4 Filing: Trieu Vuong Buys $11,475 of $OTLC
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Oncotelic Therapeutics, Inc.
Ticker: $OTLC
Transaction Value
$11,475
Price/Share: $0.04
transaction date
2026-06-24
Shares: 255,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Trieu Vuong, holds the title of CHAIRMAN AND CEO at Oncotelic Therapeutics, Inc..
On 2026-06-24, the insider transacted 255,000 shares.The shares were transacted at a weighted average price of $0.04 per share, resulting in a total market-relevant value of $11,475.
Executive Summary Summary
Trieu Vuong (CHAIRMAN AND CEO) bought $11K of $OTLC
Post-Transaction Position: 93,884,319 shares
SEC Accession No: 0001493152-26-029997 (CIK: 1587074)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.